Host innate and Th1 responses and the bacterial factors that control Mycobacterium tuberculosis infection

Current Opinion in Immunology

Volumn 17, Issue 4 SPEC. ISS., 2005, Pages 374-380

  Salgame, Padmini ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GLYCOLIPID; LIPOPROTEIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

BACTERIAL INFECTION; BACTERIAL STRAIN; CELLULAR IMMUNITY; CHRONIC INFLAMMATION; GRANULOMA; HOST CELL; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNOPROPHYLAXIS; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; INFECTION; INNATE IMMUNITY; LYMPH FOLLICLE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHAGOSOME; REVIEW; TH1 CELL;

EID: 20544462785     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2005.06.006     Document Type: Article

References (50)

1. S.R. Krutzik, and R.L. Modlin The role of Toll-like receptors in combating mycobacteria Semin Immunol 16 2004 35 41
2. •].
3. • ] provide good evidence that Toll-like receptor 2 (TLR2) signaling is anti-inflammatory in the context of an M. tuberculosis infection.
4. E.H. Noss, R.K. Pai, T.J. Sellati, J.D. Radolf, J. Belisle, D.T. Golenbock, W.H. Boom, and C.V. Harding Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis J Immunol 167 2001 910 918
5. S.M. Fortune, A. Solache, A. Jaeger, P.J. Hill, J.T. Belisle, B.R. Bloom, E.J. Rubin, and J.D. Ernst Mycobacterium tuberculosis inhibits macrophage responses to IFN-γ through myeloid differentiation factor 88-dependent and -independent mechanisms J Immunol 172 2004 6272 6280
6. V. Redecke, H. Hacker, S.K. Datta, A. Fermin, P.M. Pitha, D.H. Broide, and E. Raz Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma J Immunol 172 2004 2739 2743
7. B. Pulendran, P. Kumar, C.W. Cutler, M. Mohamadzadeh, T. Van Dyke, and J. Banchereau Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo J Immunol 167 2001 5067 5076
8. S. Dillon, A. Agrawal, T. Van Dyke, G. Landreth, L. McCauley, A. Koh, C. Maliszewski, S. Akira, and B. Pulendran A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells J Immunol 172 2004 4733 4743
9. S. Agrawal, A. Agrawal, B. Doughty, A. Gerwitz, J. Blenis, T. Van Dyke, and B. Pulendran Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos J Immunol 171 2003 4984 4989
10. N. Reiling, C. Holscher, A. Fehrenbach, S. Kroger, C.J. Kirschning, S. Goyert, and S. Ehlers Cutting edge: Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis J Immunol 169 2002 3480 3484
11. I. Sugawara, H. Yamada, C. Li, S. Mizuno, O. Takeuchi, and S. Akira Mycobacterial infection in TLR2 and TLR6 knockout mice Microbiol Immunol 47 2003 327 336
12. C.A. Scanga, A. Bafica, C.G. Feng, A.W. Cheever, S. Hieny, and A. Sher MyD88-deficient mice display a profound loss in resistance to Mycobacterium tuberculosis associated with partially impaired Th1 cytokine and nitric oxide synthase 2 expression Infect Immun 72 2004 2400 2404
13. C.M. Fremond, V. Yeremeev, D.M. Nicolle, M. Jacobs, V.F. Quesniaux, and B. Ryffel Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88 J Clin Invest 114 2004 1790 1799 An intriguing paper demonstrating that the TLR-MyD88 signaling pathway is necessary for host resistance but dispensable for a normal adaptive response in mice infected with M. tuberculosis.
14. dim/intermediate dendritic cells is crucial for T cell recruitment to lungs infected with Mycobacterium tuberculosis J Immunol 172 2004 7647 7653
15. K. Bhatt, S.P. Hickman, and P. Salgame Cutting edge: a new approach to modeling early lung immunity in murine tuberculosis J Immunol 172 2004 2748 2751
16. H.M. Algood, and J.L. Flynn CCR5-deficient mice control Mycobacterium tuberculosis infection despite increased pulmonary lymphocytic infiltration J Immunol 173 2004 3287 3296
17. D.O. Co, L.H. Hogan, S.I. Kim, and M. Sandor Mycobacterial granulomas: keys to a long-lasting host-pathogen relationship Clin Immunol 113 2004 130 136
18. T. Ulrichs, G.A. Kosmiadi, V. Trusov, S. Jorg, L. Pradl, M. Titukhina, V. Mishenko, N. Gushina, and S.H. Kaufmann Human tuberculous granulomas induce peripheral lymphoid follicle-like structures to orchestrate local host defence in the lung J Pathol 204 2004 217 228
19. J.A. Armstrong, and P.D. Hart Response of cultured macrophages to M. tuberculosis with observations of fusion of lysosomes with phagosomes J Exp Med 134 1971 713 740
20. D.G. Russell Phagosomes, fatty acids and tuberculosis Nat Cell Biol 5 2003 776 778
21. K. Pethe, D.L. Swenson, S. Alonso, J. Anderson, C. Wang, and D.G. Russell Isolation of Mycobacterium tuberculosis mutants defective in the arrest of phagosome maturation Proc Natl Acad Sci USA 101 2004 13642 13647
22. A. Walburger, A. Koul, G. Ferrari, L. Nguyen, C. Prescianotto-Baschong, K. Huygen, B. Klebl, C. Thompson, G. Bacher, and J. Pieters Protein kinase G from pathogenic mycobacteria promotes survival within macrophages Science 304 2004 1800 1804
23. U.E. Schaible, S. Sturgill-Koszycki, P.H. Schlesinger, and D.G. Russell Cytokine activation leads to acidification and increases maturation of Mycobacterium avium-containing phagosomes in murine macrophages J Immunol 160 1998 1290 1296
24. L.E. Via, R.A. Fratti, M. McFalone, E. Pagan-Ramos, D. Deretic, and V. Deretic Effects of cytokines on mycobacterial phagosome maturation J Cell Sci 111 1998 897 905
25. E.D. Chan, J. Chan, and N.W. Schluger What is the role of nitric oxide in murine and human host defense against tuberculosis? Am J Respir Cell Mol Biol 25 2001 606 612
26. J.D. MacMicking, G.A. Taylor, and J.D. McKinney Immune control of tuberculosis by IFN-γ-inducible LRG-47 Science 302 2003 654 659 The authors of this paper present strong evidence for a NOS2-independent and IFN-γ-dependent mechanism of suppressing M. tuberculosis replication.
27. M.G. Gutierrez, S.S. Master, S.B. Singh, G.A. Taylor, M.I. Colombo, and V. Deretic Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages Cell 119 2004 753 766 A beautiful piece of work showing that arrest of mycobacterial phagosome maturation can be reversed by signals induced by the process of autophagy. Yet another host mechanism of suppressing M. tuberculosis replication.
28. K.B. Hisert, M.A. Kirksey, J.E. Gomez, A.O. Sousa, J.S. Cox, W.R. Jacobs Jr., C.F. Nathan, and J.D. McKinney Identification of Mycobacterium tuberculosis counterimmune (cim) mutants in immunodeficient mice by differential screening Infect Immun 72 2004 5315 5321
29. A.M. Talaat, R. Lyons, S.T. Howard, and S.A. Johnston The temporal expression profile of Mycobacterium tuberculosis infection in mice Proc Natl Acad Sci USA 101 2004 4602 4607
30. P.C. Karakousis, T. Yoshimatsu, G. Lamichhane, S.C. Woolwine, E.L. Nuermberger, J. Grosset, and W.R. Bishai Dormancy phenotype displayed by extracellular Mycobacterium tuberculosis within artificial granulomas in mice J Exp Med 200 2004 647 657
31. J. Chan, and J. Flynn The immunological aspects of latency in tuberculosis Clin Immunol 110 2004 2 12 An excellent review on latency in tuberculosis.
32. J.M. Tufariello, J. Chan, and J.L. Flynn Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection Lancet Infect Dis 3 2003 578 590
33. M.A. Gardam, E.C. Keystone, R. Menzies, S. Manners, E. Skamene, R. Long, and D.C. Vinh Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management Lancet Infect Dis 3 2003 148 155
34. + cells in vivo during Mycobacterium tuberculosis infection J Immunol 172 2004 6846 6857
35. B.R. Bloom, P. Salgame, and B. Diamond Revisiting and revising T suppressor cells Immunol Today 13 1992 131 136
36. + Tregs: limiting collateral damage J Clin Invest 114 2004 1372 1378
37. S. Mendez, S.K. Reckling, C.A. Piccirillo, D. Sacks, and Y. Belkaid Role for CD4(+) CD25(+) regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity J Exp Med 200 2004 201 210
38. V.A. Boussiotis, E.Y. Tsai, E.J. Yunis, S. Thim, J.C. Delgado, C.C. Dascher, A. Berezovskaya, D. Rousset, J.M. Reynes, and A.E. Goldfeld IL-10-producing T cells suppress immune responses in anergic tuberculosis patients J Clin Invest 105 2000 1317 1325
39. R.M. Warren, T.C. Victor, E.M. Streicher, M. Richardson, N. Beyers, N.C. van Pittius, and P.D. van Helden Patients with active tuberculosis often have different strains in the same sputum specimen Am J Respir Crit Care Med 169 2004 610 614
40. C.L. Cosma, O. Humbert, and L. Ramakrishnan Superinfecting mycobacteria home to established tuberculous granulomas Nat Immunol 5 2004 828 835 An excellent study designed to track the fate of super-infecting mycobacteria.
41. A. van Rie, R.M. Warren, N. Beyers, R.P. Gie, C.N. Classen, M. Richardson, S.L. Sampson, T.C. Victor, and P.D. van Helden Transmission of a multidrug-resistant Mycobacterium tuberculosis strain resembling "strain W" among noninstitutionalized, human immunodeficiency virus-seronegative patients J Infect Dis 180 1999 1608 1615
42. M. Zhang, J. Gong, Z. Yang, B. Samten, M.D. Cave, and P.F. Barnes Enhanced capacity of a widespread strain of Mycobacterium tuberculosis to grow in human macrophages J Infect Dis 179 1999 1213 1217
43. C. Manca, L. Tsenova, A. Bergtold, S. Freeman, M. Tovey, J.M. Musser, C.E. Barry III, V.H. Freedman, and G. Kaplan Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/β Proc Natl Acad Sci USA 98 2001 5752 5757
44. O.S. Toungoussova, P. Sandven, A.O. Mariandyshev, N.I. Nizovtseva, G. Bjune, and D.A. Caugant Spread of drug-resistant Mycobacterium tuberculosis strains of the Beijing genotype in the Archangel Oblast Russia J Clin Microbiol 40 2002 1930 1937
45. C. Manca, M.B. Reed, S. Freeman, B. Mathema, B. Kreiswirth, C.E. Barry III, and G. Kaplan Differential monocyte activation underlies strain-specific Mycobacterium tuberculosis pathogenesis Infect Immun 72 2004 5511 5514
46. S.A. Theus, M.D. Cave, and K.D. Eisenach Intracellular macrophage growth rates and cytokine profiles of Mycobacterium tuberculosis strains with different transmission dynamics J Infect Dis 191 2005 453 460
47. M.B. Reed, P. Domenech, C. Manca, H. Su, A.K. Barczak, B.N. Kreiswirth, G. Kaplan, and C.E. Barry III A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response Nature 431 2004 84 87 The first study to demonstrate a direct link between strain variation and virulence.
48. C.L. Cosma, D.R. Sherman, and L. Ramakrishnan The secret lives of the pathogenic mycobacteria Annu Rev Microbiol 57 2003 641 676
49. H. Pan, B.S. Yan, M. Rojas, Y.V. Shebzukhov, H. Zhou, L. Kobzik, D.E. Higgins, M.J. Daly, B.R. Bloom, and I. Kramnik Ipr1 gene mediates innate immunity to tuberculosis Nature 434 2005 767 772 An outstanding paper identifying a candidate tuberculosis susceptibility gene, Ipr1, whose gene product controls innate immunity, cell death and pathogenesis in tuberculosis.
50. V. Rao, N. Fujiwara, S.A. Porcelli, and M.S. Glickman Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector molecule J Exp Med 201 2005 535 543